Your browser doesn't support javascript.
loading
Germline BRCA variants, lifestyle and ovarian cancer survival.
Gersekowski, Kate; Delahunty, Rachel; Alsop, Kathryn; Goode, Ellen L; Cunningham, Julie M; Winham, Stacey J; Pharoah, Paul; Song, Honglin; Jordan, Susan; Fereday, Sian; DeFazio, Anna; Friedlander, Michael; Obermair, Andreas; Webb, Penelope M.
Afiliação
  • Gersekowski K; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Delahunty R; Women's Cancer Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria 3010, Australia.
  • Alsop K; Women's Cancer Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria 3010, Australia.
  • Goode EL; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Cunningham JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Winham SJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Pharoah P; Department of Public Health and Primary Care, University of Cambridge, Centre for Cancer Genetic Epidemiology, Cambridge, UK; Department of Oncology, University of Cambridge, Centre for Cancer Genetic Epidemiology, Cambridge, UK.
  • Song H; Department of Public Health and Primary Care, University of Cambridge, Cardiovascular Epidemiology Unit, Cambridge, UK.
  • Jordan S; School of Public Health, University of Queensland, Brisbane, Queensland, Australia.
  • Fereday S; Women's Cancer Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria 3010, Australia.
  • DeFazio A; Department of Gynaecological Oncology, Westmead Hospital, Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia.
  • Friedlander M; Prince of Wales Clinical School University of New South Wales, Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
  • Obermair A; Queensland Centre for Gynaecological Cancer Research, The University of Queensland, Brisbane, Queensland, Australia.
  • Webb PM; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Electronic address: penny.webb@qimrberghofer.edu.au.
Gynecol Oncol ; 165(3): 437-445, 2022 06.
Article em En | MEDLINE | ID: mdl-35400525
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Genes BRCA2 Limite: Female / Humans País/Região como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Genes BRCA2 Limite: Female / Humans País/Região como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article